<< Previous Story----Next Story >>

DRUG NAME	PHARMA COMPANY	PURPOSE	STAGE
480848	GlaxoSmithKline	Prevent atherosclerosis and heart attack	Late-stage trial
Acomplia	Sanofi-Synthelabo	Combat obesity; reduce risk of heart disease	Awaiting regulatory decision
AGI-1067	AtheroGenics	Combat artery inflammation	Late-stage trial
Alfimeprase	Nuvelo	Clot-buster	Late-stage trial
Celacade	Vasogen	Treat heart failure	Late-stage trial
DG031	DeCode Genetics	Combat artery inflammation	Mid-stage trial
ETC-216	Pfizer	Remove cholesterol from arteries	Mid-stage trial
Lipitor-torcetrapib	Pfizer	Raise good cholesterol	Late-stage trial
PPAR alpha agonist	Eli Lilly/Ligand Pharmaceuticals	Raise good cholesterol, lower triglycerides	Mid-stage trial
Rasilez	Novartis	Reduce high blood pressure	Late-stage trial
Thelin	Encysive Pharmaceuticals	Treat pulmonary hypertension	Awaiting regulatory decision
Acapodene	GTx	Prostate cancer prevention	Late-stage trial
AP23573	Ariad Pharmaceuticals	Sarcoma	Mid-stage trial
Dasatinib	Bristol-Myers Squibb	Leukemia	Awaiting regulatory decision
Ipilumumab	Medarex	Melanoma	Late-stage trial
Panitumumab	Amgen	Colon cancer, other tumors	Awaiting regulatory decision
PTK-787	Novartis/Schering	Colon cancer	Late-stage trial
Provenge	Dendreon	Prostate cancer	Late-stage trial
Telcyta	Telik	Ovarian cancer	Late-stage trial
Ticilimumab	Pfizer	Melanoma	Mid-stage trial
Tykerb	GlaxoSmithKline	Breast cancer, bladder cancer	Late-stage trial
Arxxant	Eli Lilly	Treat diabetes complications	Late-stage trial
Galida	AstraZeneca	Lower blood sugar and cholesterol	Late-stage trial
Galvus	Novartis	Control blood sugar	Late-stage trial
Januvia	Merck	Control blood sugar	Late-stage trial
NXY-059	Renovis/AstraZeneca	Stroke	Late-stage trial
Champix	Pfizer	Smoking addiction	Late-stage trial
Flurizan	Myriad Genetics	Alzheimer's disease	Late-stage trial
Gaboxadol	Merck	Sleeplessness	Late-stage trial
Indiplon	Neurocrine Biosciences	Sleeplessness	Late-stage trial
Tysabri	Biogen Idec	Multiple sclerosis	FDA-approved but withdrawn
Zeven	Pfizer	Treats bacterial infections	Awaiting regulatory decision
Denosumab	Amgen	Treats osteoporosis	Mid-stage trial
Lucentis	Genentech	Treats macular degeneration	Mid-stage trial
LymphoStat-B	Human Genome Sciences/GlaxoSmithKline	Treats lupus, rheumatoid arthritis	Mid-stage trial
Maraviroc	Pfizer	Treats HIV/AIDS	Late-stage trial
MYO-029	Wyeth	Treats muscular dystrophy	Early-stage clinical trial

<< Previous Story----Next Story >>